Cargando…

Medulloblastoma Presenting As Isolated Leptomeningeal Enhancement With No Primary Mass

Medulloblastoma presenting with diffuse leptomeningeal enhancement and no identified intra-parenchymal primary mass is extremely rare. A 14-year-old previously healthy boy presented with a three-week history of symptoms consistent with increased intracranial pressure (ICP). Magnetic resonance imagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Meister, Molly, Lin, Julian J, Bach, Sarah E, Kapileshwarkar, Yamini, Kumar, Prerna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352599/
https://www.ncbi.nlm.nih.gov/pubmed/35936137
http://dx.doi.org/10.7759/cureus.26598
_version_ 1784762683054096384
author Meister, Molly
Lin, Julian J
Bach, Sarah E
Kapileshwarkar, Yamini
Kumar, Prerna
author_facet Meister, Molly
Lin, Julian J
Bach, Sarah E
Kapileshwarkar, Yamini
Kumar, Prerna
author_sort Meister, Molly
collection PubMed
description Medulloblastoma presenting with diffuse leptomeningeal enhancement and no identified intra-parenchymal primary mass is extremely rare. A 14-year-old previously healthy boy presented with a three-week history of symptoms consistent with increased intracranial pressure (ICP). Magnetic resonance imaging (MRI) revealed diffuse leptomeningeal enhancement which prompted consideration of infectious, inflammatory, and neoplastic etiologies. The patient became rapidly unstable requiring the placement of an external ventricular drain (EVD) and induction of a phenobarbital coma for refractory seizures. The “sugar-coated” appearance of the abnormal enhancement and thickened tissues raised concern specifically for malignancy. The patient remained extremely unstable and ultimately required surgical decompression for increased ICP at which time a biopsy was obtained. Despite attempting bridging intra-ventricular chemotherapy, the patient, unfortunately, passed away, just 14 days from the initial presentation. Final pathology later confirmed the diagnosis of medulloblastoma. Awareness of medulloblastoma in the differential of diffuse leptomeningeal enhancement is crucial for early identification and treatment of this rare presentation. This case is the first pediatric report of primary leptomeningeal medulloblastoma without a primary mass involving the large cell/anaplastic variant.
format Online
Article
Text
id pubmed-9352599
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-93525992022-08-05 Medulloblastoma Presenting As Isolated Leptomeningeal Enhancement With No Primary Mass Meister, Molly Lin, Julian J Bach, Sarah E Kapileshwarkar, Yamini Kumar, Prerna Cureus Neurology Medulloblastoma presenting with diffuse leptomeningeal enhancement and no identified intra-parenchymal primary mass is extremely rare. A 14-year-old previously healthy boy presented with a three-week history of symptoms consistent with increased intracranial pressure (ICP). Magnetic resonance imaging (MRI) revealed diffuse leptomeningeal enhancement which prompted consideration of infectious, inflammatory, and neoplastic etiologies. The patient became rapidly unstable requiring the placement of an external ventricular drain (EVD) and induction of a phenobarbital coma for refractory seizures. The “sugar-coated” appearance of the abnormal enhancement and thickened tissues raised concern specifically for malignancy. The patient remained extremely unstable and ultimately required surgical decompression for increased ICP at which time a biopsy was obtained. Despite attempting bridging intra-ventricular chemotherapy, the patient, unfortunately, passed away, just 14 days from the initial presentation. Final pathology later confirmed the diagnosis of medulloblastoma. Awareness of medulloblastoma in the differential of diffuse leptomeningeal enhancement is crucial for early identification and treatment of this rare presentation. This case is the first pediatric report of primary leptomeningeal medulloblastoma without a primary mass involving the large cell/anaplastic variant. Cureus 2022-07-05 /pmc/articles/PMC9352599/ /pubmed/35936137 http://dx.doi.org/10.7759/cureus.26598 Text en Copyright © 2022, Meister et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Meister, Molly
Lin, Julian J
Bach, Sarah E
Kapileshwarkar, Yamini
Kumar, Prerna
Medulloblastoma Presenting As Isolated Leptomeningeal Enhancement With No Primary Mass
title Medulloblastoma Presenting As Isolated Leptomeningeal Enhancement With No Primary Mass
title_full Medulloblastoma Presenting As Isolated Leptomeningeal Enhancement With No Primary Mass
title_fullStr Medulloblastoma Presenting As Isolated Leptomeningeal Enhancement With No Primary Mass
title_full_unstemmed Medulloblastoma Presenting As Isolated Leptomeningeal Enhancement With No Primary Mass
title_short Medulloblastoma Presenting As Isolated Leptomeningeal Enhancement With No Primary Mass
title_sort medulloblastoma presenting as isolated leptomeningeal enhancement with no primary mass
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352599/
https://www.ncbi.nlm.nih.gov/pubmed/35936137
http://dx.doi.org/10.7759/cureus.26598
work_keys_str_mv AT meistermolly medulloblastomapresentingasisolatedleptomeningealenhancementwithnoprimarymass
AT linjulianj medulloblastomapresentingasisolatedleptomeningealenhancementwithnoprimarymass
AT bachsarahe medulloblastomapresentingasisolatedleptomeningealenhancementwithnoprimarymass
AT kapileshwarkaryamini medulloblastomapresentingasisolatedleptomeningealenhancementwithnoprimarymass
AT kumarprerna medulloblastomapresentingasisolatedleptomeningealenhancementwithnoprimarymass